These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 15882244

  • 1. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
    Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchôa DM, Francesconi CF, Prolla JC.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1231-9. PubMed ID: 15882244
    [Abstract] [Full Text] [Related]

  • 2. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
    Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):55-63. PubMed ID: 16803603
    [Abstract] [Full Text] [Related]

  • 3. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL, Talley NJ, O'Moráin C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberöd A, Theodórs A, Sundin M, Bolling-Sternevald E, Junghard O.
    N Engl J Med; 1998 Dec 24; 339(26):1875-81. PubMed ID: 9862942
    [Abstract] [Full Text] [Related]

  • 4. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F, Gonvers JJ, Wietlisbach V, Burnand B, Hildebrand P, Schneider C, Saraga E, Beglinger C, Vader JP, Eradication in Dyspepsia (ERADYS) Study Group.
    Am J Gastroenterol; 2001 Aug 24; 96(8):2329-36. PubMed ID: 11513170
    [Abstract] [Full Text] [Related]

  • 5. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
    Veldhuyzen van Zanten S, Fedorak RN, Lambert J, Cohen L, Vanjaka A.
    Am J Gastroenterol; 2003 Sep 24; 98(9):1963-9. PubMed ID: 14499772
    [Abstract] [Full Text] [Related]

  • 6. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar 24; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J, Farkkilä M, Sipponen P.
    Am J Gastroenterol; 2001 Oct 24; 96(10):2866-72. PubMed ID: 11693319
    [Abstract] [Full Text] [Related]

  • 8. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U, Raps S, Plein K, Leodolter A, Hotz Dagger J, Malfertheiner P.
    Dtsch Med Wochenschr; 2004 Mar 26; 129(13):671-5. PubMed ID: 15026962
    [Abstract] [Full Text] [Related]

  • 9. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP, Cruzado AI, Garcia-Gravalos R, Pajares JM.
    Hepatogastroenterology; 2004 Mar 26; 51(55):303-8. PubMed ID: 15011890
    [Abstract] [Full Text] [Related]

  • 10. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
    Oderda G, Marinello D, Lerro P, Kuvidi M, de'Angelis GL, Ferzetti A, Cucchiara S, Franco MT, Romano C, Strisciuglio P, Pensabene L.
    Helicobacter; 2004 Aug 26; 9(4):293-301. PubMed ID: 15270743
    [Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
    Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M.
    Lancet; 2001 Jun 02; 357(9270):1738-42. PubMed ID: 11403809
    [Abstract] [Full Text] [Related]

  • 12. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, van Tulder MW, Kuipers EJ, Boers M, Dijkmans BA.
    Helicobacter; 2007 Oct 02; 12(5):477-85. PubMed ID: 17760715
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P, Iacopini F, Crispino P, Nardi F, Bella A, Rivera M, Rossi P, Gurnari M, Caracciolo F, Zippi M, Pica R.
    Helicobacter; 2006 Dec 02; 11(6):562-8. PubMed ID: 17083378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.